「fo」の検索結果
123件：36～40件目を表示
-
Supplement business | Business Activities | About Senju | SENJU Pharmaceutical
prescription and OTC drugs to contribute to the health of all people. As our next mission, we have found a way to contribute to the health of all people: the promotion of people’s health every day. I...
https://www.senju.co.jp/english/about/business/ec.html -
論文投稿実績 | 研究開発活動 | 千寿製薬株式会社
al of Ophthalmology. 2026;283:163-175. 外部リンク Cost‑effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age‑Related Macular Degeneration and its Subtypes from the Societal and Patient Pers...
https://www.senju.co.jp/rd/thesis/ -
Company Profile | About Senju | SENJU Pharmaceutical
Corporate Name Senju Pharmaceutical Co.,Ltd. Headquarter 3-1-9, Kawara-machi, Chuo-ku, Osaka 541-0048,Japan TEL：+81-6-6201-2512 FAX：+81-6-6226-0406 Date of Incorporation April 9, 1947 Capital 1,415,50
https://www.senju.co.jp/english/about/outline.html -
日文部科学・環境省令第 1 号） 9) げっ歯類の胎児・新生児の鎮痛・麻酔および安楽死に関する声明（平成 27 年 11 月 11 日 第 2 版、日本実験動物医学会） 10) The Guide for the Care and Use of LaboratoryAnimals 8th edition. National Research Council, 2011. 11) AVMA Gui...
https://www.senju.co.jp/about/rp/regulations.pdf -
製品開発方針 | 研究開発活動 | 千寿製薬株式会社
heng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106-16. #1...
https://www.senju.co.jp/rd/policy/